Visioneering Technologies
Visioneering Technologies, Inc. (VTI), headquartered in Alpharetta, Georgia, is an innovative new company that is dedicated to redefining vision. With a portfolio of technologies to address eye care issues such as presbyopia and myopia, the company uses creative and differentiated design approaches to develop products that will ultimately enhance practitioner and patient experiences.
VTI was founded by Dr. Richard A. Griffin, an optometrist, optical engineer and aerospace engineer who has spent 20 years developing VTI’s optical solutions. From Dr. Griffin's design, VTI holds twelve issued patents worldwide with 7 pending that address the need for a treatment for presbyopia in the underdeveloped on-eye/in-eye categories.
VTI brings together clinical, marketing, engineering, manufacturing and regulatory leaders from today's top vision care businesses. Together, these industry veterans bring the best thinking in eye care to design and bring to market new solutions for presbyopia, myopia and astigmatism.
Latest Media Releases
01/02/2018 09:44:00
Indications include unique NaturalVue Multifocal lens for myopia progression control
Atlanta, Georgia, USA 31 January 2018: Visioneering Technologies, Inc. (ASX:VTI), an innovative US-based medical…
Latest News
Company News /
by Adrian Tan -
25 days ago
11 Dec 2024 - Visioneering Technologies (ASX:VTI) has announced plans to delist from the ASX, with a vote scheduled for 10 January 2025.
Interviews /
by Jessica Amir -
6 years ago
01 Nov 2018 - Visioneering Technologies Limited (ASX:VTI) CEO and Executive Director, Dr Stephen Snowdy provides an update on the company's distribution agreements, its successful …
Interviews /
by Jessica Amir -
6 years ago
11 May 2018 - Visioneering Technologies Limited (ASX:VTI) CEO and Executive Director, Dr Stephen Snowdy, discusses the benefits of contact lenses for a range of conditions, includi…
Interviews /
by Jessica Amir -
6 years ago
14 Mar 2018 - Visioneering Technologies Limited (ASX:VTI) CEO and Executive Director, Dr Stephen Snowdy, discusses the company's FY17 results.
Interviews /
by Jessica Amir -
7 years ago
13 Dec 2017 - Visioneering Technologies Inc (ASX:VTI) CEO and Executive Director, Dr Stephen Snowdy, provides an update on the company, its latest myopia data results and outlook …
Interviews /
by Carolyn Herbert -
7 years ago
03 May 2017 - Visioneering Technologies (ASX:VTI) CEO and Executive Director, Dr Stephen Snowdy, discusses its revolutionary contact lenses, size of the market and strategy.
Market Reports /
by David Chau -
7 years ago
28 Mar 2017 - Best day of 2017 (so far): ASX closes 1.3% higher. Myer (ASX:MYR) claims it does not know why its share price surged yesterday, and is unaware of “potential corporate…
Market Reports /
by David Chau -
7 years ago
28 Mar 2017 - Defying negative global leads: ASX up 0.98% at noon. Southern Cross Media Group (ASX:SXL) reaches in-principle agreement to sell its northern NSW TV assets to the WIN…